Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

730 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Androgens and abdominal obesity.
Mårin P, Arver S. Mårin P, et al. Baillieres Clin Endocrinol Metab. 1998 Oct;12(3):441-51. doi: 10.1016/s0950-351x(98)80191-2. Baillieres Clin Endocrinol Metab. 1998. PMID: 10332565 Review.
Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men.
Karlsson C, Stenlöf K, Johannsson G, Mårin P, Björntorp P, Bengtsson BA, Carlsson B, Carlsson LM, Sjöström L. Karlsson C, et al. Eur J Endocrinol. 1998 Apr;138(4):408-14. doi: 10.1530/eje.0.1380408. Eur J Endocrinol. 1998. PMID: 9578508 Clinical Trial.
As compared with placebo, an overall decrease in serum leptin concentrations as assessed by the area under the curve (AUC) (P < 0.05) and an increase in BMR (AUC, P < 0.05) were observed during GH treatment. ...

As compared with placebo, an overall decrease in serum leptin concentrations as assessed by the area under the curve (AUC) (P < 0.

The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects.
Gudbjörnsdóttir S, Fowelin J, Elam M, Attvall S, Bengtsson BA, Mårin P, Lönnroth P. Gudbjörnsdóttir S, et al. Eur J Clin Invest. 1997 Jan;27(1):29-35. doi: 10.1046/j.1365-2362.1997.670617.x. Eur J Clin Invest. 1997. PMID: 9041374 Clinical Trial.

During the clamp, plasma insulin was significantly higher after metoprolol treatment than after placebo treatment (56 +/- 3 vs. 64 +/- 2 mU L(-1), P < 0.05). Consequently, the insulin sensitivity index [glucose infusion rate (GIR)/ plasma insulin] was lower after metopr

During the clamp, plasma insulin was significantly higher after metoprolol treatment than after placebo treatment (56 +/- 3 vs. 64 +/- 2 mU …
Influence of smoking on hormone secretion in obese and lean female smokers.
Szostak-Wegierek D, Björntorp P, Mårin P, Lindstedt G, Andersson B. Szostak-Wegierek D, et al. Obes Res. 1996 Jul;4(4):321-8. doi: 10.1002/j.1550-8528.1996.tb00239.x. Obes Res. 1996. PMID: 8822756 Clinical Trial.
Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.
Andersson B, Mattsson LA, Hahn L, Mårin P, Lapidus L, Holm G, Bengtsson BA, Björntorp P. Andersson B, et al. J Clin Endocrinol Metab. 1997 Feb;82(2):638-43. doi: 10.1210/jcem.82.2.3746. J Clin Endocrinol Metab. 1997. PMID: 9024268 Clinical Trial.
Blood glucose, glycosylated hemoglobin, c-peptide, total cholesterol, low-density lipoprotein cholesterol, and IGF-I decreased significantly (P < 0.01-P < 0.001), whereas high-density lipoprotein cholesterol rose (P < 0.001). ...
Blood glucose, glycosylated hemoglobin, c-peptide, total cholesterol, low-density lipoprotein cholesterol, and IGF-I decreased significantly …
Growth hormone secretion after testosterone administration to men with visceral obesity.
Mårin P, Rosmond R, Bengtsson BA, Gustafsson C, Holm G, Björntorp P. Mårin P, et al. Obes Res. 1994 May;2(3):263-70. doi: 10.1002/j.1550-8528.1994.tb00056.x. Obes Res. 1994. PMID: 16353427
Serum leptin concentration and insulin sensitivity in men with abdominal obesity.
Johannsson G, Karlsson C, Lönn L, Mårin P, Björntorp P, Sjöström L, Carlsson B, Carlsson LM, Bengtsson BA. Johannsson G, et al. Obes Res. 1998 Nov;6(6):416-21. doi: 10.1002/j.1550-8528.1998.tb00373.x. Obes Res. 1998. PMID: 9845231
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
Johannsson G, Mårin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BA. Johannsson G, et al. J Clin Endocrinol Metab. 1997 Mar;82(3):727-34. doi: 10.1210/jcem.82.3.3809. J Clin Endocrinol Metab. 1997. PMID: 9062473 Clinical Trial.

After an initial decrease in the GDR at 6 weeks, the GDR increased in the rhGH-treated group as compared with the placebo-treated one (P < 0.05). The mean serum concentrations of total cholesterol (P < 0.01) and triglyceride (P < 0.05) decreased, whe

After an initial decrease in the GDR at 6 weeks, the GDR increased in the rhGH-treated group as compared with the placebo-treated one (P
Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone.
Mårin P, Lönn L, Andersson B, Odén B, Olbe L, Bengtsson BA, Björntorp P. Mårin P, et al. J Clin Endocrinol Metab. 1996 Mar;81(3):1018-22. doi: 10.1210/jcem.81.3.8772568. J Clin Endocrinol Metab. 1996. PMID: 8772568

T administration was followed by an increase in serum concentrations from 17.7 +/- 1.1 to 32.6 +/- 1.8 nmol/L (P < 0.001) and a marked (> 50%) reduction compared with controls in lipid radioactivity in omental and retroperitoneal adipose tissues, but not in sc adipos

T administration was followed by an increase in serum concentrations from 17.7 +/- 1.1 to 32.6 +/- 1.8 nmol/L (P < 0.001) and a ma

Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study.
Ljung T, Andersson B, Bengtsson BA, Björntorp P, Mårin P. Ljung T, et al. Obes Res. 1996 May;4(3):277-82. doi: 10.1002/j.1550-8528.1996.tb00546.x. Obes Res. 1996. PMID: 8732962 Clinical Trial.
In this study, dexamethasone (dex) was administered in random order in doses of 0.05, 0.125, 0.25 and 0.5 mg at 10 p.m. with measurements of serum cortisol in the morning (8 a.m.) of this and the following day. ...In addition, the inhibition at 0.5 mg dex correlated negati …
In this study, dexamethasone (dex) was administered in random order in doses of 0.05, 0.125, 0.25 and 0.5 mg at 10 p.m. with measurem …
730 results
Jump to page
Feedback